Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Provider Notice Issued 08/10/2022

Date:    August 10, 2022

To:       Substance Use Disorder Treatment Organizations

Re:      Substance Use Prevention and Recovery (SUPR) Rate Increases Effective July 1, 2022, per Public Act 102-0699  

______________________________________________________________________________________________________________________________________________________

This notice confirms the rate increases effective July 1, 2022, for substance use treatment services pursuant to Public Act 102-0699. These increases impact Medicaid fee-for-service (FFS) claims as well as HealthChoice Illinois (HCI) managed care organization (MCO) plan claims.

The Public Act requires an increase to existing rates of 47% for all community-based substance use disorder treatment services, including, but not limited to, all of the following:

  • Admission and Discharge Assessment
  • Level 1 (Individual)
  • Level 1 (Group)
  • Level 2 (Individual)
  • Level 2 (Group)
  • Psychiatric/Diagnostic
  • Medication Monitoring (Individual)
  • Methadone as an Adjunct to Treatment

 
The federal Centers for Medicare and Medicaid Services has approved the Department of Healthcare and Family Services' State Plan amendment to implement these requirements of the Act. A SUPR Fee Schedule has been posted to the Department's website.

Questions regarding this notice may be directed to the SUPR Helpdesk at Doit.suprhelp@illinois.gov or the applicable HCI MCO plan.

 
Kelly Cunningham, Administrator
Division of Medical Programs